PET Imaging of Pancreatic Dopamine D(2) and D(3) Receptor Density with (11)C-(+)-PHNO in Type 1 Diabetes

Type 1 diabetes mellitus (T1DM) has traditionally been characterized by a complete destruction of β-cell mass (BCM); however, there is growing evidence of possible residual BCM present in T1DM. Given the absence of in vivo tools to measure BCM, routine clinical measures of β-cell function (e.g., C-p...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Nucl Med
Autori principali: Bini, Jason, Sanchez-Rangel, Elizabeth, Gallezot, Jean-Dominique, Naganawa, Mika, Nabulsi, Nabeel, Lim, Keunpoong, Najafzadeh, Soheila, Shirali, Anupama, Ropchan, Jim, Matuskey, David, Huang, Yiyun, Herold, Kevan C., Harris, Paul E., Sherwin, Robert S., Carson, Richard E., Cline, Gary W.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Society of Nuclear Medicine 2020
Soggetti:
Endocrinology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7198375/
https://ncbi.nlm.nih.gov/pubmed/31601695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.119.234013
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi